Network

spaXio is a European research and training network funded by the Marie Skłodowska-Curie Actions (MSCA) under Horizon Europe. It unites leading academic, clinical, and industrial partners to decode how metastatic niches support cancer spread, using spatial multi-omics, 3D tumoroid models, and AI-based data analysis.

The core academic partners include Paris Lodron University Salzburg (PLUS, coordinator), Aix-Marseille University (AMU), INSERM (Institut national de la santé et de la recherche médicale), University of Tübingen, Instituto de Investigaciones Biomédicas de Madrid (CSIC), Autonomous University of Madrid (UAM), Technical University of Munich (TUM), and the University of Lausanne (UNIL). The majority of these institutions are members of the European CIVIS university alliance. DeepLife, an AI-driven biotech company, complements the network as a core industrial partner.

spaXio is supported by associated partners including Sumo Technologies, 10x Genomics, Akoya Biosciences, Okomera, Phasics, Miltenyi Biotec, Molecular Devices, and Waters GmbH, who provide advanced technologies and expertise.

Together, spaXio offers interdisciplinary future-focused training to a new generation of researchers, pushing the frontiers of cancer and spatial biology research. Importantly, these efforts will be aligned with and supported by the newly founded European Society for Spatial Biology (ESSB).